ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Total Liabilities

Everything the company owes to creditors and other parties.

No reported Total Liabilities figures are available to summarize.

Total Liabilities history

Currency unavailable · from the balance sheet

No Total Liabilities data reported for this period type.

Total Liabilities vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Total Liabilities for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MGTXMeiraGTx Holdings plcMar 2026$302.79M USD+58.6%+7.7%123.8%
PRMEPrime Medicine, Inc.Mar 2026$218.03M USD-1.5%+71.4%74.0%
WVEWave Life Sciences Ltd.Mar 2026$71.81M USD-38.4%-16.3%12.3%
SLNSilence Therapeutics plcMar 2026$65.72M USD-77.9%-6.8%57.1%
PRQRProQR Therapeutics N.V.Mar 2026€61.5M EUR-21.7%-15.4%62.0%
RNAAtrium Therapeutics, Inc.Mar 2026$58.26M USD——19.9%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$54.05M USD-44.9%-31.8%22.0%
STOKStoke Therapeutics, Inc.Mar 2026$48.4M USD-14.8%-2.5%10.9%
BNTCBenitec Biopharma Inc.Mar 2026$3.67M USD-52.0%-9.4%2.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-30.1%-8.1%22.0%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.